Android app Apple app link

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$13.27
Day's range
$14.48

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/30/2026 Stifel Nicolaus Paul Matteis $28.00 $12.92   116.68%
09/27/2026 Morgan Stanley Sean Laaman $17.00 $12.56   35.35%
11/21/2025 RBC Capital Brian Abrahams $22.00 $12.22   80.03%
10/21/2024 Robert W. Baird Joel Beatty $32.00 $16.07   99.13%
04/30/2024 RBC Capital Brian Abrahams $30.00 $16.00   87.5%
04/29/2024 Stifel Nicolaus Paul Matteis $29.00 $16.00   81.25%

Contineum Therapeutics Inc. FAQ's

Contineum Therapeutics Inc. has been rated by research analysts at Stifel Nicolaus, Morgan Stanley, Robert W. Baird, RBC Capital, Leerink Partners in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.